Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...
Times Pets on MSN17h
5 Game-Changing Ways to Soothe Your Itchy Dog – #3 Works Instantly!Is your dog constantly scratching, biting, or licking their skin? Watching your furry friend suffer from endless itching can ...
7h
BuzzFeed on MSN37 Budget-Friendly Beauty Products That'll Make Your Wallet Breathe A Sigh Of ReliefA fast-drying nail concealer made with a blend of biotin and keratin to give you the strong, healthy-looking nails of your ...
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
14hon MSN
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results